Cape Bancorp About To Put More Money In Your Pocket (CBNJ)

Looking at the universe of stocks we cover at Dividend Channel, on 10/30/14, Cape Bancorp, Inc. (CBNJ) will trade ex-dividend, for its quarterly dividend of $0.06, payable on 11/18/14. As a percentage of CBNJ's recent stock price of $8.98, this dividend works out to approximately 0.67%, so look for shares of Cape Bancorp, Inc. to trade 0.67% lower — all else being equal — when CBNJ shares open for trading on 10/30/14.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for CBNJ, showing historical dividends prior to the most recent $0.06 declared by Cape Bancorp, Inc.:

CBNJ+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CBNJ is likely to continue, and whether the current estimated yield of 2.67% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of CBNJ shares, versus its 200 day moving average:

Cape Bancorp, Inc. 200 Day Moving Average Chart

Looking at the chart above, CBNJ's low point in its 52 week range is $8.89 per share, with $11.26 as the 52 week high point — that compares with a last trade of $8.98.

In Tuesday trading, Cape Bancorp, Inc. shares are currently off about 1.4% on the day.

More from Stocks

Markets Push Higher Following Fed Chair's First Testimony on Capitol Hill

Markets Push Higher Following Fed Chair's First Testimony on Capitol Hill

Elon Musk's Tweeting Obsession Is Crushing Tesla Stock Believers

Elon Musk's Tweeting Obsession Is Crushing Tesla Stock Believers

Tesla's Model 3 Teardown Shows It Is Already Profitable - Really Profitable

Tesla's Model 3 Teardown Shows It Is Already Profitable - Really Profitable

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

Jerome Powell's Testimony Isn't Changing This Strategist's 3,000 S&P 500 Target

Jerome Powell's Testimony Isn't Changing This Strategist's 3,000 S&P 500 Target